Bionano Genomics Future Growth
Future criteria checks 2/6
Bionano Genomics is forecast to grow earnings and revenue by 68.8% and 31.5% per annum respectively while EPS is expected to grow by 78.9% per annum.
Key information
68.8%
Earnings growth rate
76.2%
EPS growth rate
| Life Sciences earnings growth | 19.4% |
| Revenue growth rate | 31.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 50 | -26 | N/A | N/A | 3 |
| 12/31/2025 | 37 | -32 | N/A | N/A | 4 |
| 12/31/2024 | 29 | -104 | N/A | N/A | 3 |
| 9/30/2024 | 33 | -136 | N/A | N/A | N/A |
| 6/30/2024 | 37 | -204 | -106 | -105 | N/A |
| 3/31/2024 | 37 | -227 | -122 | -121 | N/A |
| 12/31/2023 | 36 | -232 | -127 | -125 | N/A |
| 9/30/2023 | 34 | -227 | -132 | -130 | N/A |
| 6/30/2023 | 32 | -147 | -136 | -133 | N/A |
| 3/31/2023 | 30 | -140 | -127 | -125 | N/A |
| 12/31/2022 | 28 | -133 | -128 | -125 | N/A |
| 9/30/2022 | 26 | -117 | -119 | -116 | N/A |
| 6/30/2022 | 23 | -106 | -109 | -106 | N/A |
| 3/31/2022 | 21 | -92 | -93 | -91 | N/A |
| 12/31/2021 | 18 | -72 | -73 | -72 | N/A |
| 9/30/2021 | 16 | -61 | -59 | -58 | N/A |
| 6/30/2021 | 13 | -51 | -49 | -49 | N/A |
| 3/31/2021 | 11 | -41 | -44 | -44 | N/A |
| 12/31/2020 | 9 | -41 | -38 | -38 | N/A |
| 9/30/2020 | 7 | -37 | -36 | -36 | N/A |
| 6/30/2020 | 8 | -33 | -32 | -32 | N/A |
| 3/31/2020 | 9 | -32 | -31 | -31 | N/A |
| 12/31/2019 | 10 | -30 | -30 | -30 | N/A |
| 9/30/2019 | 11 | -28 | -24 | -24 | N/A |
| 6/30/2019 | 11 | -27 | -23 | -23 | N/A |
| 3/31/2019 | 12 | -23 | -20 | -20 | N/A |
| 12/31/2018 | 12 | -18 | -20 | -20 | N/A |
| 9/30/2018 | 11 | -18 | -19 | -19 | N/A |
| 6/30/2018 | 11 | -18 | N/A | -18 | N/A |
| 3/31/2018 | 10 | -22 | N/A | -20 | N/A |
| 12/31/2017 | 10 | -23 | N/A | -21 | N/A |
| 12/31/2016 | 7 | -19 | N/A | -23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0A4K is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0A4K is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0A4K is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0A4K's revenue (31.5% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: 0A4K's revenue (31.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0A4K's Return on Equity is forecast to be high in 3 years time